Morgan Stanley analyst Sanjit Singh lowered the firm’s price target on UiPath (PATH) to $12 from $16 and keeps an Equal Weight rating on the shares. FY26 looked to be set up to be a year of stabilization after three years of NNARR declines, but this now looks “off the table” given rising uncertainty in the spending environment, the analyst tells investors in a post-earnings note. Better growth will likely be needed for shares to rebound, the analyst added.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PATH:
- M&A News: UiPath (PATH) Supercharges AI Automation with Peak Acquisition
- UiPath’s Mixed Outlook: Hold Rating Amid Federal Segment Delays and Cloud Growth Potential
- UiPath downgraded to Underperform at BofA on weak outlook, few catalysts
- UiPath price target lowered to $11 from $13 at Wells Fargo
- UiPath’s Financial Outlook Impacted by Delayed Deals and Conservative Growth Forecast Amidst Economic Challenges